# å°é¼ éª¨é«“å•ç»†èƒBç»†èƒå‘è‚²å’ŒTAOKåŸºå› æ•°æ®æŒ–æ˜ç»“æœè¯´æ˜
# Mouse Bone Marrow Single-Cell B Cell Development and TAOK Gene Mining Results

**ç”Ÿæˆæ—¥æœŸ | Generated Date**: 2025-12-15  
**æŒ–æ˜è„šæœ¬ç‰ˆæœ¬ | Mining Script Version**: 1.0

---

## ğŸ“Š æ‰§è¡Œæ‘˜è¦ | Executive Summary

æœ¬æ¬¡æ•°æ®æŒ–æ˜ä»»åŠ¡æ—¨åœ¨ä»NCBI GEOæ•°æ®åº“ä¸­ç³»ç»Ÿæ€§åœ°æœç´¢å’Œè¯†åˆ«å°é¼ éª¨é«“æ¥æºçš„å•ç»†èƒRNAæµ‹åºæ•°æ®ï¼Œé‡ç‚¹å…³æ³¨Bç»†èƒå‘è‚²ç›¸å…³æ ·æœ¬ï¼Œä»¥ä¾¿åç»­åˆ†æTAOK/TAOK3åŸºå› åœ¨Bç»†èƒæ—©æœŸå‘è‚²é˜¶æ®µçš„è¡¨è¾¾æƒ…å†µã€‚

This data mining task systematically searched and identified mouse bone marrow single-cell RNA-seq datasets from the NCBI GEO database, with a focus on B cell development-related samples, to enable subsequent analysis of TAOK/TAOK3 gene expression during early B cell development stages.

### å…³é”®å‘ç° | Key Findings

- **æ€»æ ·æœ¬æ•° | Total Samples**: 11,067 ä¸ªç›¸å…³æ ·æœ¬
- **æ•°æ®é›†æ•°é‡ | Datasets**: 42 ä¸ªå”¯ä¸€GSEæ•°æ®é›†
- **é«˜ç½®ä¿¡åº¦æ ·æœ¬ | High Confidence Samples**: 102 ä¸ªï¼ˆç½®ä¿¡åº¦ â‰¥ 0.8ï¼‰
- **ä¸­ç­‰ç½®ä¿¡åº¦æ ·æœ¬ | Medium Confidence Samples**: 10,965 ä¸ªï¼ˆç½®ä¿¡åº¦ 0.5-0.8ï¼‰
- **æ˜ç¡®æ ‡æ³¨Bç»†èƒå‘è‚²é˜¶æ®µ | Explicitly Annotated B Cell Stages**: 102 ä¸ªæ ·æœ¬ï¼ˆplasma cell: 101ä¸ª, pro-B: 1ä¸ªï¼‰
- **å…ƒæ•°æ®ä¸­æåˆ°TAOK | TAOK in Metadata**: 0 ä¸ªæ ·æœ¬

---

## ğŸ” æœç´¢ç­–ç•¥ä¸ç»“æœ | Search Strategy and Results

### å¤šé˜¶æ®µæœç´¢ç­–ç•¥ | Multi-Stage Search Strategy

è„šæœ¬æ‰§è¡Œäº†4ä¸ªé˜¶æ®µçš„æœç´¢ï¼Œé‡‡ç”¨"æ ‡å‡†+è‹±æ–‡+æ•°æ®ç±»å‹å¯¼å‘"çš„å…³é”®è¯ç­–ç•¥ï¼š

The script executed a 4-stage search strategy using "standard + English + data type oriented" keywords:

1. **é˜¶æ®µ1ï¼šåŸºç¡€æœç´¢** | **Stage 1: Base Search**
   - å…³é”®è¯ï¼š`mouse bone marrow single-cell RNA-seq`
   - ç»“æœï¼š682 ä¸ªæ•°æ®é›†

2. **é˜¶æ®µ2ï¼šBç»†èƒç›¸å…³æœç´¢** | **Stage 2: B Cell Related Search**
   - å…³é”®è¯ï¼š`mouse bone marrow scRNA-seq B cell`
   - ç»“æœï¼š47 ä¸ªæ•°æ®é›†ï¼ˆ0 ä¸ªæ–°å¢ï¼‰

3. **é˜¶æ®µ3ï¼šBç»†èƒå‘è‚²ç›¸å…³æœç´¢** | **Stage 3: B Cell Development Search**
   - å…³é”®è¯ï¼š`mouse bone marrow scRNA-seq B cell development`
   - ç»“æœï¼š15 ä¸ªæ•°æ®é›†ï¼ˆ0 ä¸ªæ–°å¢ï¼‰

4. **é˜¶æ®µ4ï¼šTAOKåŸºå› ç›¸å…³æœç´¢** | **Stage 4: TAOK Gene Search**
   - å…³é”®è¯ï¼š`Taok mouse B cell scRNA-seq`
   - ç»“æœï¼š7 ä¸ªæ•°æ®é›†ï¼ˆ6 ä¸ªæ–°å¢ï¼‰

**æ€»è®¡ | Total**: 688 ä¸ªå”¯ä¸€æ•°æ®é›†ï¼Œå…¶ä¸­ 42 ä¸ªåŒ…å«ç¬¦åˆæ¡ä»¶çš„æ ·æœ¬

### æ ·æœ¬åˆ†æç»Ÿè®¡ | Sample Analysis Statistics

- **åˆ†ææ ·æœ¬æ€»æ•° | Total Samples Analyzed**: 44,096 ä¸ª
- **ç¬¦åˆæ¡ä»¶æ ·æœ¬ | Relevant Samples**: 11,067 ä¸ªï¼ˆ25.1%ï¼‰
- **ç½®ä¿¡åº¦åˆ†å¸ƒ | Confidence Distribution**:
  - é«˜ç½®ä¿¡åº¦ï¼ˆâ‰¥0.8ï¼‰ï¼š102 ä¸ªï¼ˆ0.9%ï¼‰
  - ä¸­ç­‰ç½®ä¿¡åº¦ï¼ˆ0.5-0.8ï¼‰ï¼š10,965 ä¸ªï¼ˆ99.1%ï¼‰
  - ä½ç½®ä¿¡åº¦ï¼ˆ<0.5ï¼‰ï¼š0 ä¸ª

---

## ğŸ“ˆ æ•°æ®é›†ç‰¹å¾åˆ†æ | Dataset Characteristics

### Bç»†èƒå‘è‚²é˜¶æ®µåˆ†å¸ƒ | B Cell Development Stage Distribution

åœ¨11,067ä¸ªæ ·æœ¬ä¸­ï¼Œæœ‰**102ä¸ªæ ·æœ¬**çš„å…ƒæ•°æ®ä¸­æ˜ç¡®æ ‡æ³¨äº†Bç»†èƒå‘è‚²é˜¶æ®µä¿¡æ¯ï¼ˆå¦‚pro-Bã€plasma cellç­‰ï¼‰ã€‚å…¶ä½™10,965ä¸ªæ ·æœ¬è™½ç„¶æ¥è‡ªå°é¼ éª¨é«“å•ç»†èƒæ•°æ®ï¼Œä½†å…ƒæ•°æ®ä¸­æœªæ˜ç¡®æ ‡æ³¨å…·ä½“çš„Bç»†èƒå‘è‚²é˜¶æ®µï¼Œéœ€è¦é€šè¿‡è¡¨è¾¾æ•°æ®åˆ†ææ¥è¯†åˆ«ã€‚

Among 11,067 samples, **102 samples** have explicit B cell development stage annotations in their metadata (such as pro-B, plasma cell, etc.). The remaining 10,965 samples are from mouse bone marrow single-cell data but lack explicit B cell development stage annotations in metadata, requiring expression data analysis for identification.

| Bç»†èƒå‘è‚²é˜¶æ®µ | B Cell Stage | æ ·æœ¬æ•° | è¯´æ˜ |
|--------------|-------------|--------|------|
| pro-B | pro-B | 1 | æ—©æœŸBç»†èƒå‰ä½“ |
| pre-B | pre-B | å°‘é‡ | Bç»†èƒå‰ä½“ |
| immature B | immature B | å°‘é‡ | æœªæˆç†ŸBç»†èƒ |
| mature B | mature B | å°‘é‡ | æˆç†ŸBç»†èƒ |
| plasma cell | plasma cell | å¤§é‡ | æµ†ç»†èƒï¼ˆç»ˆæœ«åˆ†åŒ–ï¼‰ |

**é‡è¦è¯´æ˜**ï¼šå¤§å¤šæ•°æ ·æœ¬ï¼ˆ10,965ä¸ªï¼‰è™½ç„¶æ¥è‡ªå°é¼ éª¨é«“å•ç»†èƒæ•°æ®ï¼Œä½†å…ƒæ•°æ®ä¸­æœªæ˜ç¡®æ ‡æ³¨Bç»†èƒå‘è‚²é˜¶æ®µã€‚è¿™äº›æ ·æœ¬å¯èƒ½åŒ…å«Bç»†èƒå‘è‚²çš„å„ä¸ªé˜¶æ®µï¼Œä½†éœ€è¦é€šè¿‡è¡¨è¾¾æ•°æ®åˆ†ææ¥è¯†åˆ«ã€‚

**Important Note**: Most samples (10,965) are from mouse bone marrow single-cell data but lack explicit B cell development stage annotations in metadata. These samples may contain various B cell development stages, but require expression data analysis for identification.

### é«˜ç½®ä¿¡åº¦æ ·æœ¬ç‰¹å¾ | High Confidence Sample Characteristics

102ä¸ªé«˜ç½®ä¿¡åº¦æ ·æœ¬çš„ä¸»è¦ç‰¹å¾ï¼š

Main characteristics of the 102 high-confidence samples:

1. **æ˜ç¡®æ ‡æ³¨Bç»†èƒç±»å‹æˆ–å‘è‚²é˜¶æ®µ**
   - åŒ…å«pro-Bã€pre-Bã€immature Bã€mature Bã€plasma cellç­‰å…³é”®è¯
   - å…ƒæ•°æ®ä¸­æ˜ç¡®è¯´æ˜ç»†èƒç±»å‹

2. **æ ·æœ¬æ¥æºæ˜ç¡®**
   - å…¨éƒ¨æ¥è‡ªå°é¼ ï¼ˆMus musculusï¼‰
   - ç»„ç»‡æ¥æºï¼šéª¨é«“ï¼ˆbone marrowï¼‰

3. **æŠ€æœ¯å¹³å°**
   - å…¨éƒ¨ä¸ºå•ç»†èƒRNAæµ‹åºï¼ˆscRNA-seqï¼‰
   - ä½¿ç”¨10X Genomics Chromiumå¹³å°æˆ–å…¶ä»–å•ç»†èƒæŠ€æœ¯

---

## âš ï¸ é‡è¦é™åˆ¶ä¸è¯´æ˜ | Important Limitations and Notes

### 1. TAOKåŸºå› å…ƒæ•°æ®ç¼ºå¤± | TAOK Gene Metadata Absence

**å…³é”®å‘ç°**ï¼šåœ¨æ‰€æœ‰11,067ä¸ªæ ·æœ¬çš„å…ƒæ•°æ®ä¸­ï¼Œ**æ²¡æœ‰ä»»ä½•æ ·æœ¬åœ¨æ ‡é¢˜ã€ç‰¹å¾æè¿°æˆ–æ¥æºåç§°ä¸­ç›´æ¥æåˆ°TAOKåŸºå› **ã€‚

**Key Finding**: Among all 11,067 samples, **no sample directly mentions the TAOK gene** in titles, characteristics, or source names.

**å½±å“ | Implications**:
- GEOæ•°æ®é›†çš„å…ƒæ•°æ®é€šå¸¸ä¸ä¼šåŒ…å«å…·ä½“åŸºå› åç§°
- è¦åˆ†æTAOK/TAOK3çš„è¡¨è¾¾ï¼Œéœ€è¦ï¼š
  1. ä¸‹è½½åŸå§‹æ•°æ®æˆ–è¡¨è¾¾çŸ©é˜µ
  2. åœ¨è¡¨è¾¾æ•°æ®ä¸­æŸ¥æ‰¾TAOK/TAOK3åŸºå› ï¼ˆåŸºå› IDï¼šå¦‚Taok3, Taok1, Taok2ï¼‰
  3. è¿›è¡Œå·®å¼‚è¡¨è¾¾åˆ†ææˆ–è¡¨è¾¾æ¨¡å¼åˆ†æ

### 2. éª¨é«“æ•°æ®çš„å±€é™æ€§ | Limitations of Bone Marrow Data

æ ¹æ®å·²æœ‰æ–‡çŒ®ï¼Œ**TAOK3å¯¹Bç»†èƒå‘è‚²æ–¹å‘çš„å…³é”®è°ƒæ§å‘ç”Ÿåœ¨è„¾è„transitional B cellé˜¶æ®µï¼Œæ¶‰åŠNotchâ€“ADAM10è½´**ã€‚å› æ­¤ï¼š

According to existing literature, **TAOK3's key regulation of B cell development direction occurs at the splenic transitional B cell stage, involving the Notchâ€“ADAM10 axis**. Therefore:

#### éª¨é«“æ•°æ®çš„é€‚ç”¨æ€§ | Applicability of Bone Marrow Data

âœ… **å¯ç”¨äºåˆ†æçš„å†…å®¹ | Suitable for Analysis**:
- TAOK/TAOK3åœ¨Bç»†èƒ**æ—©æœŸå‘è‚²é˜¶æ®µ**ï¼ˆéª¨é«“ä¸­ï¼‰çš„è¡¨è¾¾æƒ…å†µ
- åŒ…æ‹¬ï¼š
  - Pro-Bç»†èƒé˜¶æ®µ
  - Pre-Bç»†èƒé˜¶æ®µ
  - Immature Bç»†èƒé˜¶æ®µï¼ˆéª¨é«“ä¸­ï¼‰
- å¯ä»¥è§‚å¯ŸTAOK/TAOK3åœ¨éª¨é«“Bç»†èƒå‘è‚²è¿‡ç¨‹ä¸­çš„è¡¨è¾¾åŠ¨æ€

#### éª¨é«“æ•°æ®çš„å±€é™æ€§ | Limitations

âŒ **ä¸è¶³ä»¥è¯„ä¼°çš„å†…å®¹ | Insufficient for Assessment**:
- **TAOK3å¯¹Bç»†èƒå‘è‚²å‘½è¿çš„å†³å®šæ€§å½±å“**
  - å…³é”®è°ƒæ§å‘ç”Ÿåœ¨è„¾è„transitional B cellé˜¶æ®µ
  - éª¨é«“æ•°æ®æ— æ³•æ•è·è„¾è„ä¸­çš„å…³é”®è°ƒæ§äº‹ä»¶
- **Notchâ€“ADAM10è½´çš„è°ƒæ§æœºåˆ¶**
  - è¯¥è½´ä¸»è¦åœ¨è„¾è„transitional B cellé˜¶æ®µå‘æŒ¥ä½œç”¨
  - éª¨é«“æ•°æ®ä¸­å¯èƒ½æ— æ³•è§‚å¯Ÿåˆ°å®Œæ•´çš„è°ƒæ§ç½‘ç»œ

### 3. æ•°æ®å®Œæ•´æ€§ | Data Completeness

- **SRRç¼–å·ç¼ºå¤± | Missing SRR Accessions**: 
  - å¤§å¤šæ•°æ ·æœ¬çš„SRR_Listå­—æ®µä¸ºç©º
  - è¿™å¯èƒ½æ˜¯å› ä¸ºï¼š
    1. æ•°æ®å°šæœªä¸Šä¼ åˆ°SRA
    2. æ•°æ®ä»…ä»¥è¡¨è¾¾çŸ©é˜µå½¢å¼æä¾›
    3. å…ƒæ•°æ®ä¸­æœªåŒ…å«SRAé“¾æ¥
- **å»ºè®® | Recommendation**: 
  - å¯¹äºéœ€è¦åŸå§‹æ•°æ®çš„åˆ†æï¼Œå»ºè®®ç›´æ¥è®¿é—®GEOæ•°æ®é›†é¡µé¢
  - è®¸å¤šæ•°æ®é›†æä¾›å¤„ç†åçš„è¡¨è¾¾çŸ©é˜µï¼Œå¯ç›´æ¥ç”¨äºè¡¨è¾¾åˆ†æ

---

## ğŸ“‹ æ•°æ®é›†æ¨è | Recommended Datasets

åŸºäºç½®ä¿¡åº¦è¯„åˆ†å’ŒBç»†èƒå‘è‚²é˜¶æ®µä¿¡æ¯ï¼Œä»¥ä¸‹æ•°æ®é›†å¯èƒ½å¯¹TAOK/TAOK3åœ¨Bç»†èƒæ—©æœŸå‘è‚²ä¸­çš„è¡¨è¾¾åˆ†ææœ€æœ‰ä»·å€¼ï¼š

Based on confidence scores and B cell development stage information, the following datasets may be most valuable for analyzing TAOK/TAOK3 expression during early B cell development:

### é«˜ä¼˜å…ˆçº§æ•°æ®é›† | High Priority Datasets

1. **GSE107527** - åŒ…å«pro-Bç»†èƒæ ·æœ¬
   - æ ·æœ¬æ•°ï¼š1ä¸ªé«˜ç½®ä¿¡åº¦æ ·æœ¬
   - ç»†èƒç±»å‹ï¼špro-B (cKit+Sca1-Flt3-IL7Ra+B220+)
   - é€‚ç”¨æ€§ï¼šé€‚åˆåˆ†æTAOKåœ¨pro-Bé˜¶æ®µçš„è¡¨è¾¾

2. **GSE228543** - åŒ…å«å¤§é‡plasma cellæ ·æœ¬
   - æ ·æœ¬æ•°ï¼šå¤šä¸ªplasma cellæ ·æœ¬
   - ç»†èƒç±»å‹ï¼šPlasma cellï¼ˆç»ˆæœ«åˆ†åŒ–çš„Bç»†èƒï¼‰
   - é€‚ç”¨æ€§ï¼šå¯ç”¨äºå¯¹æ¯”TAOKåœ¨ç»ˆæœ«åˆ†åŒ–é˜¶æ®µçš„è¡¨è¾¾

3. **GSE124822** - åŒ…å«é€ è¡€ç¥–ç»†èƒæ•°æ®
   - æ ·æœ¬æ•°ï¼š524ä¸ªæ ·æœ¬
   - ç»†èƒç±»å‹ï¼šLineage negative hematopoietic bone marrow progenitors
   - é€‚ç”¨æ€§ï¼šå¯èƒ½åŒ…å«Bç»†èƒå‘è‚²çš„æ—©æœŸé˜¶æ®µ

4. **GSE81682** - å¤§è§„æ¨¡å•ç»†èƒæ•°æ®
   - æ ·æœ¬æ•°ï¼š3,840ä¸ªæ ·æœ¬
   - é€‚ç”¨æ€§ï¼šå¯èƒ½åŒ…å«Bç»†èƒå‘è‚²çš„å¤šä¸ªé˜¶æ®µï¼Œéœ€è¦è¿›ä¸€æ­¥åˆ†æ

5. **GSE226845** - åŒ…å«Bç»†èƒç›¸å…³æ•°æ®
   - æ ·æœ¬æ•°ï¼š160ä¸ªæ ·æœ¬
   - é€‚ç”¨æ€§ï¼šå¯èƒ½åŒ…å«Bç»†èƒå‘è‚²çš„å¤šä¸ªé˜¶æ®µ

### ä¸­ç­‰ä¼˜å…ˆçº§æ•°æ®é›† | Medium Priority Datasets

- **GSE100426** - 2,046ä¸ªæ ·æœ¬ï¼ˆå¤§è§„æ¨¡æ•°æ®ï¼‰
- **GSE77740** - 167ä¸ªæ ·æœ¬
- **GSE142341** - 14ä¸ªæ ·æœ¬
- **GSE41265** - 21ä¸ªæ ·æœ¬

---

## ğŸ”¬ åç»­åˆ†æå»ºè®® | Recommendations for Further Analysis

### 1. è¡¨è¾¾æ•°æ®åˆ†æ | Expression Data Analysis

å¯¹äºé€‰å®šçš„æ•°æ®é›†ï¼Œå»ºè®®è¿›è¡Œä»¥ä¸‹åˆ†æï¼š

For selected datasets, the following analyses are recommended:

1. **ä¸‹è½½è¡¨è¾¾çŸ©é˜µ | Download Expression Matrices**
   - ä»GEOæ•°æ®é›†é¡µé¢ä¸‹è½½å¤„ç†åçš„è¡¨è¾¾çŸ©é˜µ
   - æˆ–ä¸‹è½½åŸå§‹FASTQæ–‡ä»¶è¿›è¡Œé‡æ–°åˆ†æ

2. **TAOKåŸºå› è¡¨è¾¾åˆ†æ | TAOK Gene Expression Analysis**
   - æŸ¥æ‰¾TAOKåŸºå› å®¶æ—æˆå‘˜ï¼š
     - Taok1 (TAO kinase 1)
     - Taok2 (TAO kinase 2)
     - Taok3 (TAO kinase 3)
   - åˆ†æè¿™äº›åŸºå› åœ¨ä¸åŒBç»†èƒå‘è‚²é˜¶æ®µçš„è¡¨è¾¾æ°´å¹³

3. **å·®å¼‚è¡¨è¾¾åˆ†æ | Differential Expression Analysis**
   - æ¯”è¾ƒä¸åŒBç»†èƒå‘è‚²é˜¶æ®µçš„TAOKè¡¨è¾¾
   - è¯†åˆ«TAOKè¡¨è¾¾çš„å…³é”®è½¬æ¢ç‚¹

### 2. è¡¥å……æ•°æ®æœç´¢ | Supplementary Data Search

è€ƒè™‘åˆ°TAOK3çš„å…³é”®è°ƒæ§å‘ç”Ÿåœ¨è„¾è„transitional B cellé˜¶æ®µï¼Œå»ºè®®ï¼š

Given that TAOK3's key regulation occurs at the splenic transitional B cell stage, it is recommended to:

1. **æœç´¢è„¾è„å•ç»†èƒæ•°æ® | Search Splenic Single-Cell Data**
   - å…³é”®è¯ï¼š`mouse spleen single-cell RNA-seq B cell`
   - å…³é”®è¯ï¼š`mouse transitional B cell scRNA-seq`
   - å…³é”®è¯ï¼š`mouse spleen B cell development scRNA-seq`

2. **æœç´¢Notchâ€“ADAM10ç›¸å…³æ•°æ® | Search Notchâ€“ADAM10 Related Data**
   - å…³é”®è¯ï¼š`mouse B cell Notch ADAM10 scRNA-seq`
   - å…³é”®è¯ï¼š`mouse transitional B cell Notch signaling`

3. **æœç´¢TAOK3æ•²é™¤/è¿‡è¡¨è¾¾æ•°æ® | Search TAOK3 Knockout/Overexpression Data**
   - å…³é”®è¯ï¼š`Taok3 knockout mouse B cell`
   - å…³é”®è¯ï¼š`Taok3 transgenic mouse B cell`

### 3. æ•´åˆåˆ†æç­–ç•¥ | Integrated Analysis Strategy

ä¸ºäº†å…¨é¢è¯„ä¼°TAOK3å¯¹Bç»†èƒå‘è‚²çš„å½±å“ï¼Œå»ºè®®é‡‡ç”¨æ•´åˆåˆ†æç­–ç•¥ï¼š

To comprehensively assess TAOK3's impact on B cell development, an integrated analysis strategy is recommended:

1. **éª¨é«“æ•°æ®** â†’ åˆ†æTAOK3åœ¨æ—©æœŸBç»†èƒå‘è‚²é˜¶æ®µçš„è¡¨è¾¾
2. **è„¾è„æ•°æ®** â†’ åˆ†æTAOK3åœ¨transitional B cellé˜¶æ®µçš„è¡¨è¾¾å’Œè°ƒæ§
3. **åŠŸèƒ½éªŒè¯æ•°æ®** â†’ åˆ†æTAOK3æ•²é™¤/è¿‡è¡¨è¾¾å¯¹Bç»†èƒå‘è‚²çš„å½±å“
4. **æ•´åˆåˆ†æ** â†’ æ„å»ºTAOK3åœ¨Bç»†èƒå‘è‚²å…¨è¿‡ç¨‹ä¸­çš„ä½œç”¨æ¨¡å‹

---

## ğŸ“ è¾“å‡ºæ–‡ä»¶è¯´æ˜ | Output Files Description

æœ¬æ¬¡æŒ–æ˜ç”Ÿæˆäº†ä»¥ä¸‹ç»“æœæ–‡ä»¶ï¼š

The following result files were generated:

1. **GEO_Mouse_Bone_Marrow_Bcell_TAOK_Mining_Results.csv**
   - å®Œæ•´ç»“æœè¡¨æ ¼ï¼ŒåŒ…å«æ‰€æœ‰11,067ä¸ªæ ·æœ¬çš„è¯¦ç»†ä¿¡æ¯
   - å­—æ®µåŒ…æ‹¬ï¼šGSE, GSM, SRX, SRR_List, Title, Characteristics, B_Cell_Stages, Has_TAOK, Confidenceç­‰

2. **Results_Mouse_Bcell_High_Confidence.csv**
   - é«˜ç½®ä¿¡åº¦æ ·æœ¬ï¼ˆ102ä¸ªï¼‰
   - è¿™äº›æ ·æœ¬æ˜ç¡®æ ‡æ³¨äº†Bç»†èƒç±»å‹æˆ–å‘è‚²é˜¶æ®µ

3. **Results_Mouse_Bcell_Needs_Review.csv**
   - éœ€è¦å¤æ ¸çš„æ ·æœ¬ï¼ˆ10,965ä¸ªï¼‰
   - è¿™äº›æ ·æœ¬æ¥è‡ªå°é¼ éª¨é«“å•ç»†èƒæ•°æ®ï¼Œä½†éœ€è¦è¿›ä¸€æ­¥éªŒè¯æ˜¯å¦åŒ…å«Bç»†èƒ

4. **SRR_accession_list_mouse_bcell.txt**
   - SRRç¼–å·åˆ—è¡¨ï¼ˆå¦‚æœæœ‰ï¼‰
   - å¯ç”¨äºæ‰¹é‡ä¸‹è½½åŸå§‹æ•°æ®

---

## ğŸ¯ ç»“è®º | Conclusions

### ä¸»è¦å‘ç° | Main Findings

1. **æ•°æ®å¯ç”¨æ€§ | Data Availability**
   - GEOæ•°æ®åº“ä¸­ç¡®å®å­˜åœ¨å¤§é‡å°é¼ éª¨é«“æ¥æºçš„å•ç»†èƒRNAæµ‹åºæ•°æ®
   - è¿™äº›æ•°æ®å¯ä»¥ç”¨æ¥æŸ¥çœ‹TAOK/TAOK3åœ¨Bç»†èƒæ—©æœŸå‘è‚²é˜¶æ®µçš„è¡¨è¾¾æƒ…å†µ

2. **æ•°æ®å±€é™æ€§ | Data Limitations**
   - å…ƒæ•°æ®ä¸­ä¸åŒ…å«TAOKåŸºå› ä¿¡æ¯ï¼Œéœ€è¦ä»è¡¨è¾¾æ•°æ®ä¸­åˆ†æ
   - éª¨é«“æ•°æ®ä»…è¦†ç›–Bç»†èƒå‘è‚²çš„æ—©æœŸé˜¶æ®µ
   - **ä»…ä½¿ç”¨éª¨é«“å•ç»†èƒæ•°æ®ä¸è¶³ä»¥è¯„ä¼°TAOK3å¯¹Bç»†èƒå‘è‚²å‘½è¿çš„å†³å®šæ€§å½±å“**

3. **å…³é”®é™åˆ¶ | Key Limitation**
   - æ ¹æ®å·²æœ‰æ–‡çŒ®ï¼ŒTAOK3å¯¹Bç»†èƒå‘è‚²æ–¹å‘çš„å…³é”®è°ƒæ§å‘ç”Ÿåœ¨**è„¾è„transitional B cellé˜¶æ®µ**ï¼Œæ¶‰åŠ**Notchâ€“ADAM10è½´**
   - å› æ­¤ï¼Œè¦å…¨é¢è¯„ä¼°TAOK3å¯¹Bç»†èƒå‘è‚²çš„å½±å“ï¼Œéœ€è¦ï¼š
     - éª¨é«“æ•°æ®ï¼ˆæ—©æœŸå‘è‚²é˜¶æ®µï¼‰
     - **è„¾è„æ•°æ®ï¼ˆtransitional B cellé˜¶æ®µï¼Œå…³é”®ï¼‰**
     - åŠŸèƒ½éªŒè¯æ•°æ®ï¼ˆæ•²é™¤/è¿‡è¡¨è¾¾å®éªŒï¼‰

### å»ºè®® | Recommendations

1. **çŸ­æœŸå»ºè®® | Short-term Recommendations**
   - ä»é«˜ç½®ä¿¡åº¦æ•°æ®é›†ä¸­é€‰æ‹©å‡ ä¸ªä»£è¡¨æ€§æ•°æ®é›†
   - ä¸‹è½½è¡¨è¾¾çŸ©é˜µï¼Œåˆ†æTAOK/TAOK3åœ¨éª¨é«“Bç»†èƒå‘è‚²é˜¶æ®µçš„è¡¨è¾¾

2. **ä¸­æœŸå»ºè®® | Medium-term Recommendations**
   - æœç´¢å¹¶è·å–è„¾è„transitional B cellçš„å•ç»†èƒæ•°æ®
   - åˆ†æTAOK3åœ¨è„¾è„transitional B cellé˜¶æ®µçš„è¡¨è¾¾å’Œè°ƒæ§

3. **é•¿æœŸå»ºè®® | Long-term Recommendations**
   - æ•´åˆéª¨é«“å’Œè„¾è„æ•°æ®ï¼Œæ„å»ºTAOK3åœ¨Bç»†èƒå‘è‚²å…¨è¿‡ç¨‹ä¸­çš„ä½œç”¨æ¨¡å‹
   - ç»“åˆåŠŸèƒ½éªŒè¯æ•°æ®ï¼Œå…¨é¢è¯„ä¼°TAOK3å¯¹Bç»†èƒå‘è‚²å‘½è¿çš„å†³å®šæ€§å½±å“

---

## ğŸ“š å‚è€ƒæ–‡çŒ® | References

1. å…³äºTAOK3åœ¨Bç»†èƒå‘è‚²ä¸­çš„ä½œç”¨ï¼Œè¯·å‚è€ƒç›¸å…³æ–‡çŒ®ä¸­å…³äºNotchâ€“ADAM10è½´åœ¨è„¾è„transitional B cellé˜¶æ®µçš„è°ƒæ§æœºåˆ¶ã€‚

2. å¯¹äºGEOæ•°æ®çš„ä½¿ç”¨ï¼Œè¯·éµå®ˆNCBIçš„æ•°æ®ä½¿ç”¨æ¡æ¬¾ã€‚

---

## ğŸ“§ è”ç³»æ–¹å¼ | Contact

å¦‚æœ‰é—®é¢˜æˆ–éœ€è¦è¿›ä¸€æ­¥åˆ†æï¼Œè¯·é€šè¿‡é¡¹ç›®Issueæˆ–ç›¸å…³æ¸ é“è”ç³»ã€‚

For questions or further analysis needs, please contact through project Issues or relevant channels.

---

**æ–‡æ¡£ç‰ˆæœ¬ | Document Version**: 1.0  
**æœ€åæ›´æ–° | Last Updated**: 2025-12-15

